There has been a further extension to SSP06 for Fluoxetine 40mg capsules. This will now be in place until 4th September 2020.
This SSP outlines procedures to follow in providing a suitable alternative product in response to the serious shortage affecting the 40mg capsules. Pharmacists must exercise their professional judgement when considering whether the alternative product is suitable for the patient.
The SSP expiry date may be brought forward or further extended, and can be amended whilst in effect.
Please ensure you are familiar with the current SSP before supplying the alternative product, and that your pharmacy team is aware of this extension and any changes to the SSP content.